Page last updated: 2024-08-22

doxifluridine and Thrombopenia

doxifluridine has been researched along with Thrombopenia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujitani, K; Furukawa, H; Goto, M; Imamoto, H; Imamura, H; Imano, M; Ishida, H; Kimura, Y; Narahara, H; Shimokawa, T; Takiuchi, H1
Abele, R; Alberto, P; Bollag, W; Germano, G; Heintz, R; Seematter, RJ1
Abele, R; Alberto, P; Cavalli, F; Hartmann, D; Hofmann, V; Holdener, EE; Kaplan, S; Ryssel, HJ; Siegenthaler, P1
Cho, JH; Kim, NK; Min, JS; Seong, J; Suh, CO1
Alberto, P; Mermillod, B; Winkelmann, JJ1

Trials

2 trial(s) available for doxifluridine and Thrombopenia

ArticleYear
Multi-center phase II study for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistance to S-1 (OGSG 0302).
    Japanese journal of clinical oncology, 2008, Volume: 38, Issue:3

    Topics: Adenocarcinoma; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Combinations; Drug Resistance, Neoplasm; Female; Floxuridine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Tegafur; Thrombocytopenia

2008
Preoperative chemoradiotherapy with oral doxifluridine plus low-dose oral leucovorin in unresectable primary rectal cancer.
    International journal of radiation oncology, biology, physics, 2001, Jun-01, Volume: 50, Issue:2

    Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diarrhea; Female; Floxuridine; Humans; Leucovorin; Male; Middle Aged; Preoperative Care; Radiotherapy; Rectal Neoplasms; Thrombocytopenia

2001

Other Studies

3 other study(ies) available for doxifluridine and Thrombopenia

ArticleYear
Phase I clinical study with 5'-deoxy-5-fluorouridine, a new fluoropyrimidine derivative.
    Cancer treatment reports, 1982, Volume: 66, Issue:6

    Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Female; Floxuridine; Half-Life; Humans; Kinetics; Leukocyte Count; Leukopenia; Male; Middle Aged; Neoplasms; Platelet Count; Stomatitis; Thrombocytopenia

1982
Phase II study of doxifluridine in advanced colorectal adenocarcinoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1983, Volume: 1, Issue:12

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Chemical Phenomena; Chemistry; Colonic Neoplasms; Drug Eruptions; Drug Evaluation; Female; Floxuridine; Heart; Humans; Leukopenia; Male; Middle Aged; Nausea; Rectal Neoplasms; Thrombocytopenia; Vomiting

1983
[Doxifluridine toxicity, a fluorouracil analog with low myelosuppressive effect].
    Bulletin du cancer, 1990, Volume: 77, Issue:3

    Topics: Administration, Oral; Antineoplastic Agents; Bone Marrow; Central Nervous System; Floxuridine; Heart; Humans; Infusions, Intravenous; Leukopenia; Thrombocytopenia

1990